Gilead to launch generic version of its controversially priced hepatitis C drugs
(By Alia Paavola for Becker’s Hospital Review) Gilead Sciences will offer a cheaper version of its blockbuster hepatitis C drugs,
Read More(By Alia Paavola for Becker’s Hospital Review) Gilead Sciences will offer a cheaper version of its blockbuster hepatitis C drugs,
Read More(By Morgan Haefner for Becker’s Hospital Review) Blue Cross Blue Shield of Michigan will pay more than 520,000 policyholders for
Read More(By Harrison Cook for Becker’s Hospital Review) Congress revealed a 660-page revised opioids bill the night of Sept. 25 as part of
Read More(By Morgan Haefner for Becker’s Hospital Review) Americans with health insurance coverage through their employer — the largest insured population
Read MoreWith more than 23,000 people dying annually in the United States from bacterial infections that have evolved to resist antibiotics,
Read MoreAn epidemiology professor and her team from the West Virginia University School of Public Health studying the potential benefits of
Read More(By Ed Silverman for STAT) As prices for diabetes treatments continue to roil consumers, a new study suggests that manufacturers
Read MoreMedicare beneficiaries can change their Medicare Advantage or Medicare Prescription drug (Part D) coverage during the Medicare Annual Election Period
Read More(By Jackie Fortier for NPR) Air ambulance rides can be lifesavers. But how much should they cost? In the ongoing,
Read More(By Jordan Rau for Kaiser Health News) On orders from Congress, Medicare is easing up on its annual readmission penalties
Read More